Agile patents expiration
1. Twirla patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8747888 | AGILE | Dermal delivery device with in situ seal |
Jul, 2028
(4 years from now) | |
| US9050348 | AGILE | Dermal delivery device |
Jul, 2028
(4 years from now) | |
| US8246978 | AGILE | Dermal delivery device with reduced loss of its volatile components |
Aug, 2028
(4 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product (NP) | Feb 14, 2023 |
Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient
Market Authorisation Date: 14 February, 2020
Treatment: NA
Dosage: SYSTEM;TRANSDERMAL
More Information on Dosage
TWIRLA family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic